Norges Bank’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Norges Bank’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-90,000	Closed	-$2.94M	–	572
2025 Q4	$2.94M	Buy	+90,000	New	+$2.91M	﹤0.01%	1428
2025 Q3	–	Sell	-120,000	Closed	-$3.36M	–	640
2025 Q2	$3.36M	Hold	120,000	–	–	﹤0.01%	1371
2025 Q1	$3.01M	Hold	120,000	–	–	﹤0.01%	1452
2024 Q4	$3.3M	Hold	120,000	–	–	﹤0.01%	1604
2024 Q3	$3.45M	Hold	120,000	–	–	﹤0.01%	1586
2024 Q2	$2.97M	Hold	120,000	–	–	﹤0.01%	1656
2024 Q1	$3.86M	Hold	120,000	–	–	﹤0.01%	1666
2023 Q4	$4.88M	Hold	120,000	–	–	﹤0.01%	1681
2023 Q3	$4.15M	Hold	120,000	–	–	﹤0.01%	1718
2023 Q2	$4.88M	Hold	120,000	–	–	﹤0.01%	1722
2023 Q1	$4.64M	Hold	120,000	–	–	﹤0.01%	1778
2022 Q4	$5.33M	Hold	120,000	–	–	﹤0.01%	1763
2022 Q3	$5.12M	Hold	120,000	–	–	﹤0.01%	1758
2022 Q2	$6.7M	Hold	120,000	–	–	﹤0.01%	1689
2022 Q1	$7.44M	Hold	120,000	–	–	﹤0.01%	1780
2021 Q4	$6.62M	Hold	120,000	–	–	﹤0.01%	1866
2021 Q3	$6.31M	Hold	120,000	–	–	﹤0.01%	1888
2021 Q2	$8.27M	Buy	120,000 +50,000	+71%	+$3.81M	﹤0.01%	1820
2021 Q1	$5.4M	Hold	70,000	–	–	﹤0.01%	1900
2020 Q4	$6.93M	Hold	70,000	–	–	﹤0.01%	1834
2020 Q3	$9.93M	Hold	70,000	–	–	﹤0.01%	1711
2020 Q2	$13.8M	Hold	70,000	–	–	﹤0.01%	1624
2020 Q1	$13.7M	Hold	70,000	–	–	﹤0.01%	1473
2019 Q4	$14.5M	Hold	70,000	–	–	﹤0.01%	1688
2019 Q3	$10.7M	Hold	70,000	–	–	﹤0.01%	1752
2019 Q2	$9.03M	Hold	70,000	–	–	﹤0.01%	1834
2019 Q1	$8.24M	Hold	70,000	–	–	﹤0.01%	1858
2018 Q4	$6.42M	Hold	70,000	–	–	﹤0.01%	1875
2018 Q3	$7.87M	Hold	70,000	–	–	﹤0.01%	1880
2018 Q2	$6.45M	Hold	70,000	–	–	﹤0.01%	1904
2018 Q1	$6.98M	Hold	70,000	–	–	﹤0.01%	1837
2017 Q4	$6.56M	Hold	70,000	–	–	﹤0.01%	1832
2017 Q3	$7.12M	Hold	70,000	–	–	﹤0.01%	1804
2017 Q2	$5.36M	Buy	+70,000	New	+$5.89M	﹤0.01%	1874

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank's LKFT Position: Q1 2026 in Review

Norges Bank sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026, closing a stake of 90,000 shares — an estimated $2.94M sold.

Norges Bank first reported a position in LKFT in Q2 2017 and held it in 34 quarters. The position peaked at $14.5M in Q4 2019. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

Norges Bank reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2026 after selling out during the quarter.
Norges Bank sold 90,000 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $2.94M.
Norges Bank first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2017 and held it in 34 quarters.
Norges Bank's Lakefront Biotherapeutics American Depositary Shares position peaked at $14.5M in Q4 2019.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Norges Bank's 13F filing for Q1 2026.